Shenzhen Salubris Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of pharmaceuticals and medical devices in China. The company is involved in the production and supply of pharmaceutical products in the fields of chronic diseases, including cardiovascular and cerebrovascular diseases, diabetes, oncology, osteoporosis, anti-infective diseases, and chronic kidney diseases. It also engages in the research and development, production, and sale of high-end interventional medical devices, such as cardiovascular and cerebrovascular, peripheral vascular, structural heart disease, electrophysiology, and cardiac rhythm management. The company was incorporated in 1998 and is headquartered in Shenzhen, China. Shenzhen Salubris Pharmaceuticals Co., Ltd. operates as a subsidiary of Salubris Pharmaceuticals Co., Ltd.
Frequently asked questions
What sector does Shenzhen Salubris Pharmaceuticals Co Ltd (002294) operate in?
Shenzhen Salubris Pharmaceuticals Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Shenzhen Salubris Pharmaceuticals Co Ltd (002294) current stock price?
As of the latest data, Shenzhen Salubris Pharmaceuticals Co Ltd stock price is CN¥35.80, with a previous close of CN¥35.80.
What is Shenzhen Salubris Pharmaceuticals Co Ltd (002294) current market capitalization?
Shenzhen Salubris Pharmaceuticals Co Ltd market cap is approximately 39.91 billion.
What is Shenzhen Salubris Pharmaceuticals Co Ltd (002294) Earnings Per Share (EPS)?
The trailing EPS is CN¥0.60, and the forward EPS is CN¥0.84.
What is Shenzhen Salubris Pharmaceuticals Co Ltd (002294) Price-to-Earnings (P/E) ratio?
Shenzhen Salubris Pharmaceuticals Co Ltd current P/E ratio is 59.67, with a forward P/E of 42.62.
Does Shenzhen Salubris Pharmaceuticals Co Ltd (002294) pay dividends?
Yes. Shenzhen Salubris Pharmaceuticals Co Ltd pays annual dividends with an annualized yield of 1.54% and an estimated annual payout of CN¥0.55 per share.
When is the next ex-dividend date for Shenzhen Salubris Pharmaceuticals Co Ltd (002294)?
The next ex-dividend date is scheduled for May 26, 2027.
What is Shenzhen Salubris Pharmaceuticals Co Ltd (002294) beta (volatility) score?
Shenzhen Salubris Pharmaceuticals Co Ltd has a beta of -0.159, indicating lower volatility than the overall market.
